Literature DB >> 26558360

Renal cell carcinoma: Review of etiology, pathophysiology and risk factors.

Nadezda Petejova1,2, Arnost Martinek1,2.   

Abstract

BACKGROUND AND AIMS: The global incidence of renal cell cancer is increasing annually and the causes are multifactorial. Early diagnosis and successful urological procedures with partial or total nephrectomy can be life-saving. However, only up to 10% of RCC patients present with characteristic clinical symptoms. Over 60% are detected incidentally in routine ultrasound examination. The question of screening and preventive measures greatly depends on the cause of the tumor development. For the latter reason, this review focuses on etiology, pathophysiology and risk factors for renal neoplasm.
METHODS: A literature search using the databases Medscape, Pubmed, UpToDate and EBSCO from 1945 to 2015. RESULTS AND
CONCLUSIONS: Genetic predisposition/hereditary disorders, obesity, smoking, various nephrotoxic industrial chemicals, drugs and natural/manmade radioactivity all contribute and enviromental risks are a serious concern in terms of prevention and the need to screen populations at risk. Apropos treatment, current oncological research is directed to blocking cancer cell division and inhibiting angiogenesis based on a knowledge of molecular pathways.

Entities:  

Keywords:  hereditary syndromes; nephrectomy; radioactivity; renal carcinogenesis; renal cell carcinoma; uranium toxicity

Mesh:

Substances:

Year:  2015        PMID: 26558360     DOI: 10.5507/bp.2015.050

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  33 in total

1.  MALDI Orbitrap Mass Spectrometry Profiling of Dysregulated Sulfoglycosphingolipids in Renal Cell Carcinoma Tissues.

Authors:  Robert Jirásko; Michal Holčapek; Maria Khalikova; David Vrána; Vladimír Študent; Zuzana Prouzová; Bohuslav Melichar
Journal:  J Am Soc Mass Spectrom       Date:  2017-03-30       Impact factor: 3.109

Review 2.  Systematic Review of Contemporary Evidence for the Management of T1 Renal Cell Carcinoma: What IRs Need to Know for Kidney Cancer Tumor Boards.

Authors:  Julie Cronan; Sean Dariushnia; Zachary Bercu; Robert Mitchell Ermentrout; Bill Majdalany; Laura Findeiss; Janice Newsome; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

3.  Renal Cell Carcinoma Metastasis to the Left Atrium.

Authors:  Aizaz Ali; Saeedullah Shah; Muhammad Furrukh
Journal:  Tex Heart Inst J       Date:  2022-05-01

4.  High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.

Authors:  SonTung NguyenHoang; Yidong Liu; Le Xu; Yuan Chang; Lin Zhou; Zheng Liu; Zongming Lin; Jiejie Xu
Journal:  Tumour Biol       Date:  2016-09-28

5.  miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5.

Authors:  Chao Yuan; Zhenhong Su; Shengjie Liao; Duanzhuo Li; Zhiwen Zhou; Yawen Wang; Mingchun Quan; Lingling Zeng; Cai Lv; Chenyi Shen; Weida Gong; Jianfeng Wu; Xiaogang Chen; Wenbing Hu; Xu Lv; Wenxia Si; Xin Yu
Journal:  Cancer Cell Int       Date:  2021-07-21       Impact factor: 5.722

6.  Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0/G1 phase.

Authors:  Long-Sheng Wang; Shao-Jun Chen; Jun-Feng Zhang; Meng-Nan Liu; Jun-Hua Zheng; Xu-Dong Yao
Journal:  BMC Urol       Date:  2017-05-30       Impact factor: 2.264

7.  The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy.

Authors:  Jae-Wook Chung; Dong Jin Park; So Young Chun; Seock Hwan Choi; Jun Nyung Lee; Bum Soo Kim; Hyun Tae Kim; Tae-Hwan Kim; Eun Sang Yoo; Seok-Soo Byun; Eu Chang Hwang; Seok Ho Kang; Sung-Hoo Hong; Jinsoo Chung; Cheol Kwak; Yong- June Kim; Yun-Sok Ha; Tae Gyun Kwon
Journal:  Sci Rep       Date:  2020-07-20       Impact factor: 4.379

8.  Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.

Authors:  Jun Luo; Yi Xie; Yuxiao Zheng; Chenji Wang; Feng Qi; Jiateng Hu; Yaoting Xu
Journal:  Cancer Med       Date:  2020-04-20       Impact factor: 4.452

9.  LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma.

Authors:  Chunxiu Yang; Jingjing Pang; Jian Xu; He Pan; Yueying Li; Huainian Zhang; Huan Liu; Shu-Yuan Xiao
Journal:  Cancer Cell Int       Date:  2021-07-03       Impact factor: 5.722

10.  Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma.

Authors:  Xiaohui Zhou; Huimei Huang; Wanmeng Cui; Yifang Wang; Wenqi Luo; Liudmila Matskova; Xiaoying Zhou
Journal:  Med Sci Monit       Date:  2020-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.